The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Propensity Score Methods for Confounding Control in Nonexperimental Research
Open accessAbstract
Nonexperimental studies are increasingly used to investigate the safety and effectiveness of medical products as they are used in routine care. One of the primary challenges of such studies is confounding, systematic differences in prognosis between patients exposed to an intervention of interest and the selected comparator group. In the presence of uncontrolled confounding, any observed difference in outcome risk between the groups cannot be attributed solely to a causal effect of the exposure on the outcome. Confounding in studies of medical products can arise from a variety of different sociomedical processes.1 The most common form of confounding arises from good medical practice, physicians prescribing medications and performing procedures on patients who are most likely to benefit from them. This leads to a bias known as confounding by indication, which can cause medical interventions to appear to cause events that they prevent.2,3 Conversely, patients who are perceived by a physician to be near the end of life may be less likely to receive preventive medications, leading to confounding by frailty or comorbidity.4–6 Additional sources of confounding bias can result from patients’ health-related behaviors. For example, patients who initiate a preventive medication may be more likely than other patients to engage in other healthy, prevention-oriented behaviors leading to bias known as the healthy user/adherer effect.7–9 Many statistical approaches can be used to remove the confounding effects of such factors if they are captured in the data. The most common statistical approaches for confounding control are based on multivariable regression models of the outcome. To yield unbiased estimates of treatment effects, these approaches require that the researcher correctly models the effect of the treatment and covariates on the outcome. However, correct specification of an outcome model can be challenging, particularly in studies …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Causal Diagrams for Epidemiologic Research
Greenland, S., Pearl, J., & Robins, J. M. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00008 · Cited by 3,728
Air Pollution and Hospital Admissions for Heart Disease in Eight U.S. Counties
Schwartz, J. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00005 · Cited by 3,038
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 2,877
A structural approach to selection bias
Hernán, M. A., Hernández-Díaz, S., & Robins, J. M. (2004) · Epidemiology · doi:10.1097/01.ede.0000135174.63482.43 · Cited by 2,844
Constructing Inverse Probability Weights for Marginal Structural Models
Cole, S. R., & Hernan, M. A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn164 · Cited by 2,796 · cited 2×
“Stabilized weights do not increase or decrease bias but can increase precision in the estimated treatment effects by reducing the variance of the weights.(16,21,22) For standardized mortality ratio weighted (SMRW) estimation, treated patients are given a weight of 1 whereas weights for control patients are defined as…”
BackgroundMethodVariable Selection for Propensity Score Models
Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336
Self-citationOveradjustment bias and unnecessary adjustment in epidemiologic studies.
Schisterman, E. F., Cole, S. R., & Platt, R. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a819a1 · Cited by 2,096 · cited 1×
“If the cause of the large weights is unmeasured confounding, however, trimming may decrease bias.(39) In this case, the disadvantage of losing the causal interpretation would be moot because generalizability is no longer relevant in the setting of a biased estimator.”
BackgroundDoubly robust estimation in missing data and causal inference models
Bang, H., & Robins, J. M. (2005) · Biometrics · doi:10.1111/j.1541-0420.2005.00377.x · Cited by 1,998
(2009) · Cited by 1,811
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,782
Immortal Time Bias in Pharmacoepidemiology
Suissa, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm324 · Cited by 1,708
Lunceford, J. K., & Davidian, M. (2004) · Statistics in Medicine · doi:10.1002/sim.1903 · Cited by 1,674
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646 · cited 1×
“Many design issues can be addressed through the use of incident user designs and active comparators.(44) However, even with careful design and appropriate statistical adjustment, it is unlikely that all biases within healthcare database research can be completely addressed.”
BackgroundA meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353
McCaffrey, D. F., Ridgeway, G., & Morral, A. R. (2004) · Psychological Methods · doi:10.1037/1082-989x.9.4.403 · Cited by 1,317 · cited 1×
“Various strategies for PS variable and model selection based on the evaluation of covariate balance have been proposed.(29) Once the PS model is fit and the estimated PSs are generated, it is common to plot the frequency distribution (or estimated density function) of the PS within each treatment group.”
MethodDoubly robust estimation of causal effects
Funk, M. J., Westreich, D., Wiesen, C., Stürmer, T., Brookhart, M. A., & Davidian, M. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq439 · Cited by 1,158 · cited 1×
“One principled approach to combining regression and PS weighting is through the use of the augmented IPTW estimator.(23,24) This estimator depends on both a PS and multivariable outcome model and results in an estimate of the ATE.”
MethodSelf-citationSchneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a663cc · Cited by 1,128 · cited 2×
“This is advantageous in studies using healthcare databases that provide a large number of weak confounders.(34) As we have described, in the presence of treatment effect heterogeneity, different approaches to using the PS result in estimates of different treatment effects (contrasts).”
MethodSelf-citationCepeda, M. S. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg115 · Cited by 859 · cited 2×
“However, correct specification of an outcome model can be challenging, particularly in studies involving many confounders, rare outcomes, or strong treatment effect heterogeneity that must be correctly modeled.(10) Propensity score (PS) models are an approach for estimating treatment effects that do not rely on modeli…”
BackgroundKurth, T., Walker, A. M., Glynn, R. J., Chan, K. A., Gaziano, J. M., Berger, K., & Robins, J. M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj047 · Cited by 730
Stürmer, T., Joshi, M., Glynn, R. J., Avorn, J., Rothman, K. J., & Schneeweiss, S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.07.004 · Cited by 670
Self-citationMarginal Structural Models as a Tool for Standardization
Sato, T., & Matsuyama, Y. (2003) · Epidemiology · doi:10.1097/01.ede.0000081989.82616.7d · Cited by 455
Sturmer, T., Rothman, K. J., Avorn, J., & Glynn, R. J. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq198 · Cited by 446
Brookhart, M. A., Patrick, A. R., Dormuth, C., Avorn, J., Shrank, W., Cadarette, S. M., & Solomon, D. H. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm070 · Cited by 381
Self-citationConfounding Control in Healthcare Database Research: Challenges and Potential Approaches
Brookhart, M. A., Stürmer, T., Glynn, R. J., Rassen, J., & Schneeweiss, S. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181dbebe3 · Cited by 377
Self-citationBrown, N. J., Ray, W. A., Snowden, M., & Griffin, M. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90161-7 · Cited by 313 · cited 1×
“Furthermore, the risk of angioedema is known to vary across race and may be heterogeneous across other subgroups.(41) The PS approach allows us to estimate a population treatment effect without the need to”
BackgroundShapiro, S. (1997) · PubMed · Cited by 299
Effects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates
Myers, J. A., Rassen, J. A., Gagne, J. J., Huybrechts, K. F., Schneeweiss, S., Rothman, K. J., Joffe, M. M., & Glynn, R. J. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr364 · Cited by 291
Evaluating uses of data mining techniques in propensity score estimation: a simulation study
Setoguchi, S., Schneeweiss, S., Brookhart, M. A., Glynn, R. J., & Cook, E. F. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1555 · Cited by 271
Self-citationCole, S. R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg206 · Cited by 270
Statin Adherence and Risk of Accidents: A Cautionary Tale
Dormuth, C. R., Patrick, A. R., Shrank, W. H., Wright, J. M., Glynn, R. J., Sutherland, J., & Brookhart, M. A. (2009) · Circulation · doi:10.1161/circulationaha.108.824151 · Cited by 244
Self-citationParadoxical Relations of Drug Treatment with Mortality in Older Persons
Glynn, R. J., Knight, E. L., Levin, R., & Avorn, J. (2001) · Epidemiology · doi:10.1097/00001648-200111000-00017 · Cited by 181
Makani, H., Messerli, F. H., Romero, J., Wever-Pinzon, O., Korniyenko, A., Berrios, R. S., & Bangalore, S. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.03.034 · Cited by 175
Leenen, F. H. H., Nwachuku, C. E., Black, H. R., Cushman, W. C., Davis, B. R., Simpson, L. M., Alderman, M. H., Atlas, S. A., Basile, J. N., Cuyjet, A. B., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000231662.77359.de · Cited by 171
Walker, A. M. (1996) · PubMed · Cited by 167
Patrick, A. R., Schneeweiß, S., Brookhart, M. A., Glynn, R. J., Rothman, K. J., Avorn, J., & Stürmer, T. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2098 · Cited by 166
Self-citationSelective prescribing led to overestimation of the benefits of lipid-lowering drugs
Glynn, R. J., Schneeweiß, S., WANG, P., LEVIN, R., & Avorn, J. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.12.012 · Cited by 126
Stürmer, T., Rothman, K. J., & Glynn, R. J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1231 · Cited by 121
Self-citationLunt, M., Solomon, D. H., Rothman, K. J., Glynn, R., Hyrich, K. L., Symmons, D. P. M., & Stürmer, T. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwn391 · Cited by 104
Self-citationDo Instrumental Variables Belong in Propensity Scores?
Bhattacharya, J., & Vogt, W. (2007) · doi:10.3386/t0343 · Cited by 81
Kramer, M. S., Wilkins, R., Goulet, L., Séguin, L., Lydon, J., Kahn, S. R., McNamara, H., Dassa, C., Dahhou, M., Masse, A., et al. (2009) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2009.01042.x · Cited by 58
Piller, L. B., Ford, C. E., Davis, B. R., Nwachuku, C., Black, H. R., Oparil, S., Retta, T. M., & Probstfield, J. L. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05689.x · Cited by 50
Associations of Kidney Function with Cardiovascular Medication Use after Myocardial Infarction
Winkelmayer, W. C., Levin, R., & Setoguchi, S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02010408 · Cited by 45
Johannes, C. B., Koro, C. E., Quinn, S. G., Cutone, J. A., & Seeger, J. D. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1356 · Cited by 43
Renin–angiotensin system inhibitors and angioedema: anesthetic implications
Stojiljković, L. (2012) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e328352dda5 · Cited by 21
Ellis, A., Dusetzina, S., Hansen, R., Gaynes, B., Farley, J., & Stürmer, T. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2013.01.004 · Cited by 7
Self-citation
Cited by
Taiwan’s National Health Insurance Research Database: past and future
Hsieh, C.-Y., Su, C.-C., Shao, S.-C., Sung, S.-F., Lin, S.-J., Yang Kao, Y.-H., & Lai, E. C.-C. (2019) · Clinical Epidemiology · doi:10.2147/clep.s196293 · Cited by 1,213
Desai, R. J., & Franklin, J. M. (2019) · BMJ · doi:10.1136/bmj.l5657 · Cited by 657
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD
Xie, Y., Bowe, B., Li, T., Xian, H., Balasubramanian, S., & Al-Aly, Z. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121377 · Cited by 337
Simonsen, E., Lund, L. C., Ernst, M. T., Hjellvik, V., Hegedüs, L., Hamann, S., Jørstad, Ø. K., Gulseth, H. L., Karlstad, Ø., & Pottegård, A. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16316 · Cited by 85
Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study
Huang, R.-Y., Hsieh, K.-P., Huang, W.-W., & Yang, Y.-H. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.181362 · Cited by 83
Metadata
- Authors
- Brookhart, M. A., Wyss, R., Layton, J. B., & Stürmer, T.
- Venue
- Circulation: Cardiovascular Quality and Outcomes
- Published
- 2013-09
- Volume
- 6
- Issue
- 5
- Pages
- 604-611
- ISSN
- 1941-7705 (ISSN-L)
- 1941-7713
- OpenAlex
- W2136975742
- Cited by
- 588
- References
- 47
- FWCI
- 20.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.